Compare UNFI & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNFI | VCEL |
|---|---|---|
| Founded | 1976 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1996 | 1997 |
| Metric | UNFI | VCEL |
|---|---|---|
| Price | $40.66 | $36.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $37.13 | ★ $57.50 |
| AVG Volume (30 Days) | ★ 712.2K | 417.8K |
| Earning Date | 03-10-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 236.54 |
| EPS | N/A | ★ 0.25 |
| Revenue | ★ $31,753,000,000.00 | $258,716,999.00 |
| Revenue This Year | $2.45 | $18.02 |
| Revenue Next Year | $2.09 | $18.52 |
| P/E Ratio | ★ N/A | $145.81 |
| Revenue Growth | 1.45 | ★ 14.05 |
| 52 Week Low | $20.78 | $29.24 |
| 52 Week High | $43.29 | $58.77 |
| Indicator | UNFI | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 62.70 | 46.06 |
| Support Level | $38.37 | $33.30 |
| Resistance Level | $41.90 | $36.17 |
| Average True Range (ATR) | 1.37 | 1.51 |
| MACD | 0.16 | -0.13 |
| Stochastic Oscillator | 77.18 | 50.47 |
United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.